BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3859253)

  • 1. [Acute hyperleukocytic lymphoblastic leukemia (greater than or equal to 100,000 leukocytes/mm3). Metabolic changes during induction treatment. Study, prevention and treatment].
    Leverger G; Tourani JM; Beuzeboc P; Schaison G
    Arch Fr Pediatr; 1985 Apr; 42(4):295-9. PubMed ID: 3859253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute lymphoblastic leukemia with hyperleucocytosis: an urgent problem during initial treatment (author's transl)].
    Harousseau JL; Tobelem G; Schaison G; Jacquillat C
    Nouv Presse Med; 1979 May; 8(22):1827-30. PubMed ID: 289098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypocalcemia and hyperuricemia during treatment of acute lymphoblastic leukemia in childhood].
    Armata J; Depowska T
    Pol Tyg Lek; 1974 Jul; 29(30):1309-10. PubMed ID: 4527390
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperphosphatemia, hyperphosphaturia and hypocalcemia in acute lymphoblastic leukemia.
    Zusman J; Brown DM; Nesbit ME
    N Engl J Med; 1973 Dec; 289(25):1335-40. PubMed ID: 4518614
    [No Abstract]   [Full Text] [Related]  

  • 5. Thymic involvement and initial white blood count in childhood acute lymphoblastic leukemia.
    Henze G; Langermann HJ; Kaufmann U; Ludwig R; Schellong G; Stollmann B; Riehm H
    Am J Pediatr Hematol Oncol; 1981; 3(4):369-76. PubMed ID: 6949479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group].
    Skoczeń S; Balwierz W; Moryl-Bujakowska A; Pawińska K; Luszczyńska A; Balcerska A; Płoszyńska A; Chybicka A; Dobaczewski G; Juszczak K; Wachowiak J; Derwich K; Kowalczyk J; Wiśniewska-Slusarz H; Matysiak M; Krauze A; Pawelec K; Sońta-Jakimczyk D; Tomaszewska R; Wysocki M; Styczyńskii J; Swiatkiewicz V;
    Przegl Lek; 2006; 63(1):11-4. PubMed ID: 16892892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hyperleukocytosis and prevention of tumor lysis syndrome with low-dose prednisone continuous infusion in children with acute lymphoblastic leukemia.
    Ozdemir MA; Karakukcu M; Patiroglu T; Torun YA; Kose M
    Acta Haematol; 2009; 121(1):56-62. PubMed ID: 19339772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabolic and renal changes in lymphoproliferative syndromes of childhood].
    Madero López L; Muñoz Villa A; Gallego Cobos N; Onsurbe Ramírez I
    An Esp Pediatr; 1985 Feb; 22(2):107-12. PubMed ID: 3857017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of tumor lysis syndrome.
    Rampello E; Fricia T; Malaguarnera M
    Nat Clin Pract Oncol; 2006 Aug; 3(8):438-47. PubMed ID: 16894389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of elevated serum uric acid level during hyperleukocytosis in the course of acute lymphoblastic leukemia].
    Garwicz S; Halikowski B; Armata J; Cyklis R
    Pediatr Pol; 1969 Apr; 44(4):429-36. PubMed ID: 5255617
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute anuric renal failure caused by hyperphosphoremia in acute lymphoblastic leukemia. 3 cases].
    Dutel JL; Voisin P; Brière J
    Rev Med Interne; 1983 Sep; 4(3):284-8. PubMed ID: 6582544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Respiratory distress syndrome due to hyperleukocytic leukemias].
    Valdovinos Mahave MC; Salvador Osuna C; del Agua C; Lanau Arilla MP; Vicente Cámara MP
    An Med Interna; 1999 Jul; 16(7):359-60. PubMed ID: 10481337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Argentinian Group for the Treatment of Acute Leukemia: our experience in the treatment of acute lymphoblastic leukemias].
    Pavlovsky S
    Sangre (Barc); 1981; 26(5B):845-54. PubMed ID: 7034244
    [No Abstract]   [Full Text] [Related]  

  • 14. Pretreatment prognostic factors and hospitalization periods in childhood acute lymphoblastic leukemia.
    Ramot B; Modan M; Meerowitz Y; Potashnick D; Kende G; Berkowicz M
    Isr J Med Sci; 1982 Apr; 18(4):447-55. PubMed ID: 6953056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Level of tau protein in children treated for acute lymphoblastic leukemia.
    Muszyńska-Rosłan K; Krawczuk-Rybak M; Protas PT; Hołownia A
    Pediatr Neurol; 2006 May; 34(5):367-71. PubMed ID: 16647996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Disseminated intravascular coagulation as the presenting feature of lymphoblastic leukemia. Study of a case].
    Durán Suárez JR; Juncá Piera J; Zuazu Nagore J; Triginer Boixeda JM
    Med Clin (Barc); 1980 Nov; 75(9):391-3. PubMed ID: 6936572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudohyperkalemia and extreme leukocytosis.
    Bellevue R; Dosik H; Spergel G; Gussoff BD
    J Lab Clin Med; 1975 Apr; 85(4):660-4. PubMed ID: 1120932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Life-threatening hyperuricemia during cytostatic leukemia therapy].
    Schwenk HU; Schneider U
    Fortschr Med; 1982 Mar; 100(11):454-8. PubMed ID: 6951795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fever and bacteremia in children and adolescents with acute lymphoblastic leukemia.
    Green DM
    Am J Pediatr Hematol Oncol; 1982; 4(3):263-71. PubMed ID: 6959543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.
    Oudot C; Auclerc MF; Levy V; Porcher R; Piguet C; Perel Y; Gandemer V; Debre M; Vermylen C; Pautard B; Berger C; Schmitt C; Leblanc T; Cayuela JM; Socie G; Michel G; Leverger G; Baruchel A
    J Clin Oncol; 2008 Mar; 26(9):1496-503. PubMed ID: 18349402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.